Globally, approximately 300,000 men and women are diagnosed with a cancer of the brain and nervous system every year. Although significant advances have been made in understanding the biology of these cancers, the mortality rate has remained steady for more than 30 years. Immunotherapy offers potential new treatment options for this devastating set of diseases. Join Dr. David Reardon, director of Dana-Farber Cancer Institute’s Center for Neuro-Oncology, to discover new targeted therapies, immunomodulators, cancer vaccines, cell therapies, and oncolytic virus therapies currently approved or being explored in clinical trials. Don’t miss the opportunity to ask this leader in neuro-immunotherapeutics your questions.